Publication | Closed Access
p53 and pRb prevent rereplication in response to microtubule inhibitors by mediating a reversible G1 arrest.
168
Citations
0
References
1998
Year
Nocodazole TreatmentCell DeathCytoskeletonPrb Prevent RereplicationCell CycleTumor BiologyCell RegulationMicrotubule InhibitorsRadiation OncologyCancer ResearchGenome InstabilityReversible G1 ArrestCell DivisionCell BiologyCell Cycle CheckpointsTumor SuppressorSystems BiologyMedicineCell Cycle Machinery
Cell cycle checkpoints are safeguards that ensure the initiation of downstream events only after completion of upstream processes. The tumor suppressors p53 and pRb prevent initiation of a second round of replication in response to spindle inhibitors, but it has yet to be proven that this is a mitotic checkpoint response. We show that asynchronous human fibroblasts arrest in G1 with 4 N DNA content after nocodazole treatment, whereas isogenic p53- and pRb-deficient fibroblasts rereplicate. Importantly, nocodazole elicits a reversible arrest in G0-G1 synchronized normal human fibroblasts but not in isogenic p53-deficient derivatives. Furthermore, the G1 cyclin-dependent kinase inhibitors p21 and p16 also play critical roles in limiting rereplication. Hence, p53 and pRb are required during G1 to prevent entry into a replicative cycle and appear to provide a connection between the structural integrity of the microtubules and the cell cycle machinery in interphase cells.